Form 8-K - Current report:
SEC Accession No. 0001104659-16-111860
Filing Date
2016-04-15
Accepted
2016-04-15 16:45:58
Documents
1
Period of Report
2016-04-14
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K a16-8560_18k.htm 8-K 17211
  Complete submission text file 0001104659-16-111860.txt   18404
Mailing Address 101 PARK DRIVE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RY
Business Address 101 PARK DRIVE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RY 44 1235 430000
Adaptimmune Therapeutics PLC (Filer) CIK: 0001621227 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-37368 | Film No.: 161574934
SIC: 2836 Biological Products, (No Diagnostic Substances)